Relapsing Remitting Multiple Sclerosis (RRMS)

DBCOND0036413EncephalopathyImmune System Diseases

Relapsing Remitting Multiple Sclerosis (RRMS) is the indication for 14 drugs in DrugBank. It is covered by 18 curated, structured indications.

Also known as
Multiple Sclerosis, Relapsing-Remitting · relapsing/remitting Multiple sclerosis · Relapsing-Remitting Multiple Sclerosis · Relapsing Remitting Multiple Sclerosis · Relapse Remitting Multiple Sclerosis
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0328152SNOMED CT426373005MedDRA10063399UMLSC0751967

What you can answer from here — as of October 24, 2026

14Indicated drugsWith each drug's targets and mechanism
Listed above
18Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
423Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Relapsing Remitting Multiple Sclerosis (RRMS) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In